Personal information

No personal information available

Activities

Collapse all

Works (29)

Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.c.6514256
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.c.6514256.v1
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432853.v1
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432862.v1
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432856.v1
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432871.v1
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432868.v1
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432859.v1
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432865.v1
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432877.v1
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432874.v1
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432856
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432865
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432868
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432871
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432877
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432859
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432862
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432874
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Data from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432853
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Figure from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432850.v1
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Figure from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432850
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Table from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432844.v1
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Table from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432847.v1
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Table from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432844
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

Supplementary Table from WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22432847
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

WNT5A–RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer

Cancer Research
2022-11-15 | Journal article
DOI: 10.1158/0008-5472.CAN-22-1170
Contributors: Kee-Beom Kim; Dong-Wook Kim; Youngchul Kim; Jun Tang; Nicole Kirk; Yongyu Gan; Bongjun Kim; Bingliang Fang; Jae-ll Park; Yi Zheng et al.
Source: check_circle
Crossref

3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib

2021-12-11 | Preprint
DOI: 10.1101/2021.12.10.472153
Contributors: Ismail M. Meraz; Mourad Majidi; Bingliang Fang; Feng Meng; Lihui Gao; RuPing Shao; Renduo Song; Feng Li; Min Jin Ha; Qi Wang et al.
Source: check_circle
Crossref

The laboratory’s role in combating COVID-19

Critical Reviews in Clinical Laboratory Sciences
2020-08-17 | Journal article
DOI: 10.1080/10408363.2020.1776675
Contributors: Bingliang Fang; Qing H. Meng
Source: check_circle
Crossref

Peer review (2 reviews for 2 publications/grants)

Review activity for Cancer immunology and immunotherapy. (1)
Review activity for Journal of experimental & clinical cancer research. (1)
How many people are using ORCID?